Bayer Faces Roundup Weedkiller Trial Featuring Ex-Monsanto CEO’s Testimony
(Bloomberg) -- Bayer AG faces a trial over its Roundup weedkiller in which the ex-chief executive officer of its Monsanto unit will testify for the first time as to what he knew about the product's cancer risks.
Jurors in Kansas City, Missouri, are slated to hear opening arguments Tuesday in the trial of a lawsuit filed by a former Roundup user who blames the herbicide for causing him to develop non-Hodgkin lymphoma. Bayer, which acquired Roundup-maker Monsanto, has paid billions to settle tens of thousands of cases, but still faces about 30,000 suits over the product.
Hugh Grant, Monsanto's ex-CEO, was ordered by a judge to testify in the Missouri case and the state's appeals' courts upheld that ruling. It's the first Roundup trial outside California, where the company lost three cases averaging almost $50 million in damages for each consumer and defeated two other cases.
“He is absolutely going to take the witness stand,” Jim Onder, a lawyer representing plaintiff Allan Shelton, said in an interview.
Bayer said that while it has sympathy for Shelton, extensive research supports its position that Roundup isn't responsible for his illness.
The company also said in a statement that Grant's testimony is unnecessary after he gave a five-hour deposition, but “we remain confident that his participation in this trial will only strengthen our argument that the company relies on the conclusions of leading expert regulators worldwide.”
Grant led St. Louis-based Monsanto from 2003 until Bayer paid $63 billion to buy the chemical maker in 2018. In court filings, Shelton's attorneys said he was the decision-maker about how Roundup was marketed and sold over those 15 years.
Grant's turn on the witness stand comes as Bayer officials await the U.S. Supreme Court's decision on whether to hear its appeal in a Roundup case that could help the company fend off thousands of future suits.
Bayer -- which already set aside more than $11 billion to resolve Roundup suits -- is ready to add another $4.5 billion if the high court refuses to review a $25 million award to a California plaintiff.
It wants the justices to find federal herbicide regulations trump state regulatory requirements. The company's lawyers believe such a ruling would go a long way to dissuading future Roundup suits.
The case is Shelton v. Monsanto, 1816-CV17026, Missouri District Court for the 16th Judicial District (Kansas City).
©2022 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.